IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,272,000 | +19.1% | 22,500 | 0.0% | 0.18% | +3.4% |
| Q3 2020 | $1,068,000 | -19.5% | 22,500 | 0.0% | 0.18% | -24.1% |
| Q2 2020 | $1,327,000 | +0.6% | 22,500 | -19.4% | 0.23% | -9.7% |
| Q1 2020 | $1,319,000 | -29.9% | 27,900 | -10.4% | 0.26% | -21.2% |
| Q4 2019 | $1,882,000 | +0.9% | 31,150 | 0.0% | 0.33% | -17.9% |
| Q3 2019 | $1,866,000 | -10.0% | 31,150 | -3.4% | 0.40% | -11.6% |
| Q2 2019 | $2,073,000 | -35.6% | 32,250 | -18.7% | 0.45% | -37.7% |
| Q1 2019 | $3,218,000 | – | 39,650 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |